NASDAQ:OPGN - OpGen, Inc.
$1.44
 $0.00
0.00%
1:55PM EDT
2019-02-15
OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  OPGN     avg for
industry  
  avg for
sector  
42 stocks weight:  13. 08   0. 00   0. 00  
42 stocks rank:  3. 85 K 1. 86 K 1. 09 K
# analyst opinions:  2. 00   14. 92   14. 43  

quick ratio:  1. 31   5. 37   1. 81  
current ratio:  1. 56   5. 69   2. 19  

target price low:  1. 46   88. 97   117. 82  
target price avg:  1. 91   115. 19   141. 96  
target price high:  3. 20   143. 40   163. 16  
1-yr high:  2. 80   124. 30   142. 77  
last close:  1. 44   101. 85   127. 84  
50-day avg:  1. 34   98. 27   122. 46  
200-day avg:  1. 71   99. 72   122. 70  
1-yr low:  0. 90   78. 19   100. 16  
volume:  59. 68 K 2. 38 M 4. 64 M
50-day avg volume:  174. 76 K 3. 31 M 4. 94 M
200-day avg volume:  169. 31 K 3. 23 M 4. 28 M

1-day return:  3. 60 % 0. 22 % 0. 48 %
this week return:  1. 41 % 1. 77 % 2. 01 %
12-wk return:  24. 14 % 6. 56 % 3. 33 %
52-wk return:  -35. 71 % -2. 23 % 14. 35 %

enterprise value (EV):  9. 50 M 55. 17 B 104. 51 B
market cap:  12. 58 M 49. 01 B 96. 46 B
EBITDA:  -11. 75 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -0. 81   -91. 79   2. 29  
enterprise/revenue (EV/R):  2. 99   29. 84   23. 39  
total revenue:  3. 18 M 11. 28 B 40. 22 B
total debt:  1. 96 M 13. 73 B 16. 57 B
debt/equity:  48. 67   258. 01   110. 73  
net income (common):  -12. 60 M 2. 37 B 3. 58 B

shares outstanding:  8. 65 M 607. 99 M 1. 22 B
shares:  7. 93 M 605. 53 M 1. 15 B
shares short:  500. 41 K 11. 62 M 12. 55 M
shares short prior month:  406. 24 K 11. 95 M 13. 44 M
short ratio:  2. 12   4. 82   3. 10  
short % of float:  8. 76 % 6. 19 % 2. 82 %
total cash/share:  0. 55   12. 02   11. 46  
total cash:  4. 74 M 7. 41 B 7. 37 B
free cash flow:  -7. 33 M 95. 99 M 2. 04 B
operating cash flow:  -11. 48 M 164. 74 M 3. 04 B

book value:  0. 63   14. 43   28. 26  
price/book:  2. 30   -1. 57   -2. 97  
gross profits:  -5. 81 M 8. 28 B 18. 09 B
operating margins:  -391. 11 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  -130. 66 % 49. 33 % 54. 53 %

1-yr max volatility:  -21. 30 % --- ---
1-yr mean volatility:  -0. 03 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 76   3. 03   4. 09  
forward EPS:  -0. 93   4. 33   6. 99  
P/E:  -0. 52   6. 11   26. 91  
forward P/E:  -1. 53   8. 38   10. 48  
PE/G:  0. 02   0. 37   5. 61  
growth:  -25. 90 % 683. 72 % 104. 79 %
earnings high:  -0. 42   1. 27   1. 66  
earnings avg:  -0. 42   1. 01   1. 53  
earnings low:  -0. 42   0. 76   1. 40  
revenue high:  750. 00 K 2. 86 B 11. 19 B
revenue avg:  750. 00 K 2. 78 B 10. 84 B
revenue low:  750. 00 K 2. 67 B 10. 64 B
return on assets:  -84. 26 % -3. 27 % 3. 81 %
return on equity:  -323. 50 % 107. 48 % 27. 82 %
revenue growth:  -25. 90 % 648. 36 % 97. 70 %
revenue/share:  0. 70   14. 68   59. 83  

beta (1yr vs S&P500):  0. 45   1. 21   0. 93  
sharpe (1yr):  -0. 08   0. 06   0. 98  

held % insiders:  4. 42 % 6. 46 % 3. 21 %
held % institutions:  14. 87 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : OPGN
.        + 0 =             0 :: INITIAL WEIGHT
.  + 661.472 =       661.472 :: inverse volume-to-price addition
.  + 263.239 =       924.711 :: spline projection addition
.  - 162.651 =        762.06 :: poor performance penalty
.     x 0.81 =       617.143 :: one-year gains+dividend factor
.    x 4.017 =      2479.267 :: 13 weeks' performance factor
.    x 1.492 =      3700.278 :: industry recommendation factor
.      x 1.1 =        4071.1 :: EV/R factor
.    x 0.992 =      4036.798 :: return on assets factor
.    x 0.968 =      3906.207 :: return on equity factor
.    x 0.997 =       3896.09 :: revenue growth factor
.    x 2.275 =      8861.735 :: current ratio factor
.    x 1.675 =     14841.243 :: quick ratio factor
.    x 1.213 =     18004.442 :: short ratio factor
.    x 2.023 =     36422.382 :: price-to-book factor
.     x 1.09 =     39709.527 :: debt-to-equity factor
.     x 1.05 =     41675.322 :: 5-day avg > 50-day avg
.    x 2.174 =     90608.997 :: P/E weight
.    x 2.209 =    200151.569 :: PE/G factor
.    x 1.415 =    283260.039 :: beta factor
.    x 0.079 =     22487.567 :: sharpe factor
.    x 1.127 =     25341.262 :: target low factor
.     x 1.19 =     30166.399 :: target mean factor
.    x 1.111 =      33501.42 :: target high factor
.    x 1.066 =     35699.542 :: industry 12-weeks return
.    x 0.998 =     35622.079 :: "drift" penalty 5 days ago
.    x 0.991 =     35287.029 :: overall "drift" factor
.    x 0.999 =     35253.472 :: largest single-day jump factor
.    x 0.064 =      2239.738 :: low price factor
.      x 1.0 =      2239.888 :: factor hist industry gain for week 06
.   cubeRoot =        13.084 :: reduced for readability
.                     13.084 :: FINAL WEIGHT for NASDAQ:OPGN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org